Response to Representative Schakowsky’s Questions for the Record for House Energy & Commerce Committee (Subcommittee on Consumer Protection and Commerce) Hearing on 'Profits Over Consumers: Exposing How Pharmaceutical Companies Game the System'

Response to Representative Schakowsky’s Questions for the Record, 2019

2 Pages Posted: 13 Jan 2020

Date Written: October 22, 2019

Abstract

After my testimony at the House Energy & Commerce Committee hearing, I addressed Rep. Schakowsky's questions relating to a potential FTC report on product hopping.

I explained that such a report would be helpful in obtaining information on the frequency and types of "product hopping" (by which drug companies switch from one version of a drug to another to delay generic entry). A report also would shed light on the potential anticompetitive harms of "soft switches" (in which the old drug is left on the market).

Finally, I discussed the types of information that could appear in the report, including the extent of product hopping and the effects on profitability and consumers.

Keywords: product hopping, drugs, pharmaceuticals, FTC

JEL Classification: I18, K21, L40, L41, L43, L65, O34, O38

Suggested Citation

Carrier, Michael A., Response to Representative Schakowsky’s Questions for the Record for House Energy & Commerce Committee (Subcommittee on Consumer Protection and Commerce) Hearing on 'Profits Over Consumers: Exposing How Pharmaceutical Companies Game the System' (October 22, 2019). Response to Representative Schakowsky’s Questions for the Record, 2019, Available at SSRN: https://ssrn.com/abstract=3507863

Michael A. Carrier (Contact Author)

Rutgers Law School ( email )

217 North Fifth Street
Camden, NJ 08102-1203
United States
856-225-6380 (Phone)
856-225-6516 (Fax)

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
6
Abstract Views
161
PlumX Metrics